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IntroductIon
A key event in αβ T cell–mediated interactions is the binding 
of the TCR to its ligand in the form of short peptides, which 
are bound to MHC molecules on the surface of APCs. To 
accommodate the vast amount of antigens presented by vari-
ous MHC molecules, T cells must generate a diverse αβ TCR 
repertoire. T cells achieve that task by recombining each one 
of the multiple germline-encoded variable (V), diversity (D), 
and joining (J) gene segments; nontemplate additions/dele-
tions of nucleotides in the V(D)J junctional region; and ran-
dom αβ chain pairing (Davis and Bjorkman, 1988). Each T 
cell expresses a unique TCR. Upon encountering antigens, 
TCRs also undergo conformational adjustments, a so-called 
induced-fit binding, to ensure specific recognition of respec-
tive peptide-MHCs (pMHCs; Krogsgaard and Davis, 2005).
An old question is how T cells, with such TCR di-
versity (theoretically ∼1015 clonotypes) and TCR plasticity, 
react almost exclusively in a MHC-restricted fashion and can 
react to almost any MHC molecule, considering the great 
polymorphism of MHC genes (∼15,000 variants in humans; 
Robinson et al., 2003). Positive selection during T cell devel-
opment in the thymus imposes self-MHC restriction on T 
cells because only αβ T cells that bind to self-pMHC com-
plexes with low affinity receive a survival signal (Davis and 
Bjorkman, 1988; Jameson et al., 1995). Approximately 15% of 
thymocytes induce signaling for thymic selection; of which, 
half are negatively selected, likely because of too great an af-
finity for self-pMHC and cross-reactivity (Merkenschlager et 
al., 1997; McDonald et al., 2015). The relatively high pro-
portion of MHC-reactive T cells in the preselection pool 
(∼5–20%) or the fact that ∼10% of the peripheral T cells 
are MHC alloreactive indicates an intrinsic affinity of TCRs 
toward MHC (Blackman et al., 1986; Zerrahn et al., 1997; 
Suchin et al., 2001; Blattman et al., 2002). Namely, the germ-
line-encoded complementarity determining region (CDR) 
1 and CDR2 of the Vα and Vβ segments are evolutionarily 
conserved to react with MHC molecules, which was termed 
TCR germline bias (Huseby et al., 2005; Marrack et al., 
2008; Garcia et al., 2009).
Compelling evidence for this hypothesis resulted from 
structural and mutational analysis, showing that single amino 
acid substitutions in a mouse Vβ CDR2, e.g., Tyr48, Tyr50, and 
Glu54, decreased positive selection in a TCR transgenic mouse 
model (Dai et al., 2008; Scott-Browne et al., 2009). Further-
more, some Vβ genes of jawed vertebrates (frog, shark, trout, 
and lizard), which diverged from mammals ∼400 million years 
ago, share sequences in the CDR2 region of mouse Vβ8.2 but 
otherwise exhibit little similarity. T cells with chimeric TCRs, 
containing such Vβ genes, e.g., derived from frogs, were pos-
itively selected in mice (Scott-Browne et al., 2011). Further 
evidence is mounting from the growing database of TCR–
pMHC ternary, crystallographic structures (Rossjohn et al., 
2015). With few exceptions (Beringer et al., 2015; Rossjohn et 
al., 2015), many of the solved TCR–pMHC structures to date 
have adapted a diagonal docking topology atop the pMHC 
complex. Namely, the CDR1 and CDR2 domains of TCRα 
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or β chains fix over the α2 and α1 helix of MHC class I (MHC 
I) or β and α helix of MHC II, whereas the CDR3α and the 
CDR3β are mainly in contact with the presented peptide, 
respectively (Rossjohn et al., 2015; Adams et al., 2016).
However, not all V gene segments share conserved res-
idues in CDR1 and CDR2. Therefore, it was suggested that 
each V segment engages to its cognate MHC through a menu 
of structurally coded recognition motifs that have arisen evo-
lutionarily (Feng et al., 2007; Marrack et al., 2008; Garcia 
et al., 2009), a comprehensive hypothesis, which, however, is 
difficult to address experimentally. A number of similarly con-
vincing studies, including the demonstration of antibody-like 
T cells that developed in coreceptor and MHC-deficient mice 
and some structural analyses of TCR–pMHC complexes did 
not support the TCR germline bias for MHC. Hence, it is not 
generally accepted that TCR and MHC coevolved (Tynan et 
al., 2005; Gras et al., 2010; Sethi et al., 2011; Tikhonova et al., 
2012; Van Laethem et al., 2013; Beringer et al., 2015), which 
is not surprising, given the complex and flexible interactions 
that TCR and MHC can undergo.
Structural and mutational analysis of TCR–pMHC 
complexes depicts only a few of the billions of different pos-
sible combinations. Therefore, we wished to address the prob-
lem differently, based on several assumptions. We reasoned 
that thymic selection is the most sensitive readout to detect 
subtle differences in affinity between a defined MHC mol-
ecule and any given TCR. Even though mouse TCRs can 
be selected on human MHC (Kievits et al., 1987; Ito et al., 
1996) and human TCRs can be selected on mouse MHC (Li 
et al., 2010), we assumed that mouse and human TCR and 
MHC gene loci further coevolved after their divergence ∼75 
million years ago (Waterston et al., 2002), resulting in changes 
in thymic selection of a polyclonal repertoire, depending 
on whether the TCR–pMHC interaction was specific for 
inter- or intraspecies. Therefore, we employed mice with a 
polyclonal human αβ TCR repertoire, which were deficient 
for mouse αβ TCRs and expressed either a single human 
MHC II (HLA-DRA/HLA-DRB1*0401; HLA-DR4, 
hereafter) or a single-mouse MHC II gene (I-Ab). TCR 
deep-sequencing of peripheral CD4 T cells from both mouse 
lines revealed distinct differences in their repertoire, compat-
ible with coevolution of TCR and MHC.
results
Human tcr gene loci transgenic mice with 
mouse or human MHc II gene
ABabDII and ABabDR4 mice, which both contain complete 
human TCRα and TCRβ gene loci and a single MHC II, 
mouse I-Ab, or human HLA-DR4, were employed in this 
study. Both strains are deficient for mouse αβ TCRs. ABabDII 
mice contain the HLA-A*0201 gene and are deficient for 
mouse MHC I expression (β2m- and Db-deficient), whereas 
ABabDR4 mice contain two mouse MHC I genes (Kb and 
Db). HLA-A*0201 and HLA-DR4 are both chimeric mol-
ecules allowing mouse CD8 and CD4 coreceptor binding, 
respectively. The α1 and β1 regions of I-Ab share 56 and 
61% homology with the human HLA-DR4 molecule at the 
amino acid level. Even though I-Ab and HLA-DR4 are not 
the closest homologues to each other, the TCR repertoire 
selected by either molecule can be compared, assuming that 
different MHC II alleles have similar ability to select a diverse 
repertoire. The cortical and medullary thymic epithelial cells, 
as well as thymic DCs, which are critical for positive and neg-
ative selection of T cells (Klein et al., 2014), expressed com-
parable levels of MHC II in the two mouse strains (Fig. S1).
reduced thymic selection by mouse MHc II 
compared with human MHc II
ABabDII and ABabDR4 mice contained comparable levels of 
double-positive, CD4 single-positive, and CD8 single-positive 
cells, as well as CD3+ thymocytes (Fig. 1, A and B). However, 
ABabDR4 mice contained more CD5/CD69-positive thy-
mocytes (2.106 ± 0.5 × 106 cells) than ABabDII mice did (1.3 
× 106 ± 0.3 × 106 cells), indicating that more T cells received 
a positive/negative selection signal (Fig. 1, A and B). How-
ever, thymocyte development in ABabDII and ABabDR4 
mice was less efficient than it was in C57BL/6 mice (Fig. 1).
In the periphery, ABabDR4 had more CD4 T cells 
than ABabDII mice had, which, however, did not reach sta-
tistical significance (Fig. 1 C). However, conventional CD4 
T cell (Tcon; FoxP3−CD4+CD3+) numbers were signifi-
cantly greater in the periphery in ABabDR4 compared with 
ABabDII mice (Fig.  1  D). Regulatory T cell (Treg; Fox-
P3+CD4+CD3+) numbers in both the thymus and spleen in 
ABabDII mice were comparable to those in ABabDR4 mice, 
but the frequency of Treg within the CD4 T cells was sub-
stantially greater in ABabDII (19.9 ± 4.4%) compared with 
ABabDR4 mice (10.8 ± 4.0%; Fig. 1 D and Fig. S2, A and B).
Similar numbers and frequencies of Treg cells expressed 
high levels of CD44, a homeostatic proliferation marker for 
naive T cells, although greater frequency of Tcon cells in 
ABabDII mice were CD44hi (51.7 ± 6.1%) compared with 
ABabDR4 mice (30.0 ± 15.1%; Fig. 1 D and Fig. S2, A and 
C). Treg cells and Tcon cells had similar Vβ usages in both 
ABabDII and ABabDR4 mice, based on staining with 24 
human Vβ antibodies (Fig. S2 D).
Because ABabDII and ABabDR4 mice had comparable 
frequencies of peripheral CD8 T cells, it is unlikely that the 
different MHC I molecules shaped the development of CD4 T 
cells (Fig. 1 C). Collectively, these data showed that the devel-
opment of CD4 T cells with human TCRs differed depending 
on whether they were selected by mouse or human MHC II.
diverse but nonrandom V-J usage in both mice and humans
We compared the αβ TCR repertoire of CD4 T cells of 
ABabDII and ABabDR4 mice by quantitative deep sequenc-
ing. The CD8 T cell repertoires were not sequenced because 
ABabDR4 possess two MHC I alleles, whereas ABabDII 
mice have only one human MHC I. We included similar 
numbers of naive (CD62L+/CD45RO−) CD4 T cells from 
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Figure 1. t cell development in c57Bl/6, ABabdII, and ABabdr4 mice. (A) Thymocyte staining. First lane, CD4, CD8 double- and single-positive cells; second 
lane, CD5 and CD69 staining; third lane, CD3 staining, gated on living lymphocytes; and fourth lane, CD4 and CD8 double- and single-positive cells gated on CD3+ 
cells. One representative FACS plot from each of C57BL/6 (n = 3), ABabDII (n = 6), and ABabDR4 (n = 6) mice. Percentage of the gated cells for the whole population is 
indicated inside or above the gates. (B) Numbers of CD4 single-positive, CD5+CD69+, CD4CD8 double-positive, and CD3+CD4+ thymocytes. (C, left) Representative FACS 
plots of CD4 and CD8 staining from splenocytes, gated on CD3+ living lymphocytes. (C, right) Absolute numbers of CD4 T cells from spleen of C57BL/6, ABabDII, and 
ABabDR4 mice. The percentage of positive cells is indicated in both A and C. (D) Tcon (left) and Treg (right) cell numbers from spleen. Bars with lighter color indicate the 
CD44+ portion of cells from each subgroup. Summarized data (B, C, and D) from C57BL/6 (n = 3), ABabDII (n = 6), and ABabDR4 (n = 6) mice, shown as means ± SD. 
**, 0.001 ≤ P < 0.05; *, 0.05 ≤ P < 0.1; n.s., not significant (Mann-Whitney test, two-tailed). In addition, Fig. S2 shows FoxP3 thymic and spleen staining.
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three human donors as a case of TCR selection on multi-
ple MHC II alleles. All CD4 T cells were isolated by FACS 
sort with purities >97%. We wish to point out, however, that 
certain parameters, such as V(D)J usage frequency or CDR3 
length, but not repertoire diversity, can be compared between 
the mice and humans because humans contain a set of six 
different MHC II alleles by which the T cells were selected. 
Genomic DNA from ∼2.5 × 105 purified CD4 T cells from 
ABabDII and ABabDR4 mice and ∼1.8 × 105 from human 
were submitted for sequencing. Between 0.6 × 107 and 1.6 × 
107 valid reads were obtained (Table 1).
We analyzed V and J gene usages from both in-frame 
and out-of-frame TCRs, where the out-of-frame TCRs ap-
proximated the preselection pool (Zvyagin et al., 2014). Even 
though many T cells with functional TCR rearrangement are 
not positively selected and, thus, are part of the preselection 
pool (McDonald et al., 2015), the out-of-frame TCRs in T 
cells selected by their second functional TCR represents an 
unbiased estimate of V–J usage frequency. Both, the Vα and 
Vβ gene usage in the preselection repertoire did not dif-
fer between the two mouse groups because ABabDII and 
ABabDR4 mice shared the same TCR transgene loci and 
employed the same TCR recombination enzymes for rear-
rangement (i.e., RAG proteins).
Most Vα and Vβ genes were found to be rearranged, ex-
cept for TRBV5-1, TRBV6-1, and TRAV1, which were pre-
viously reported to be missing or not expressed in the ABab 
transgenic mice (Fig.  2, A and B; Li et al., 2010). Humans 
showed a similar out-of-frame V gene usage. However, some 
Vα and Vβ genes were either more frequently (e.g., TRAV16, 
TRAV39, TRBV23-1, TRBV25-1, TRBV27, TRBV28) or 
less frequently (e.g., some of the most 5′ located Vα genes, 
TRBV9, TRBV10-1, TRBV6-5, TRBV19) used in the two 
mouse lines compared with humans. The reason for these 
differences is not clear but could be related, in some cases, 
to polymorphisms. For example, in the promoter region of 
TRAV39, a deletion of five nucleotides (TTT TC; available 
from GenBank under accession no. NC_000014, positions 22 
and 125–22,130) was detected in the mouse samples, com-
pared with the TRAV39 gene in the three human donors. A 
similar polymorphism (TTT TC deletion) has been observed 
in the CD4 promoter, which was associated with lower pro-
moter activity (Kristiansen et al., 2004).
Both Vα and Vβ gene usage was nonrandom (P < 0.0001, 
χ2 test: actual frequencies to the random gene frequency usage; 
Fig. 2). The preference for Vα and Vβ gene usage appeared to 
be different. Vα genes that were closer to the 5′ region of 
the gene locus were underrepresented. Vβ genes located in 
the 5′ and 3′ region were preferentially rearranged similarly 
in mice and humans (i.e., TRBV12-3/4, TRBV21-1, and 
TRBV27; Fig. 2 B). Jα and Jβ usage was also nonrandom and 
similar between the transgenic mice and humans (Fig. 2, C 
and D), although the four Jα segments located closest to the 
5′ end were used more frequently in mice than in humans. 
Table 1. In-frame and out-of-frame tcrα/β diversity
TCR Source In-frame nt 
clonotypes
In-frame amino acid 
clonotypes
In-frame amino acid 
clonotypes (%)
Out-of-frame 
clonotypes
Out-of-frame clono-
types (%)
Summary read
TCRα ABabDII 8 × 104 6.8 × 104 0.70 10 × 104 0.54 1.5 × 107
9 × 104 7.6 × 104 0.68 12 × 104 0.54 1.0 × 107
9 × 104 7.6 × 104 0.68 13 × 104 0.56 1.3 × 107
10 × 104 8.2 × 104 0.68 14 × 104 0.56 1.2 × 107
8 × 104 7.0 × 104 0.70 11 × 104 0.56 1.1 × 107
ABabDR4 14 × 104 10.8 × 104 0.65 20 × 104 0.58 1.6 × 107
12 × 104 9.5 × 104 0.66 1.8 × 104 0.59 1.0 × 107
11 × 104 8.7 × 104 0.68 1.7 × 104 0.59 1.0 × 107
13 × 104 10.7 × 104 0.65 20 × 104 0.59 1.4 × 107
13 × 104 10.4 × 104 0.65 18 × 104 0.56 1.3 × 107
Humans 21 × 104 18.6 × 104 0.77 21 × 104 0.49 1.3 × 107
18 × 104 15.2 × 104 0.78 15 × 104 0.45 1.0 × 107
12 × 104 10.4 × 104 0.80 8.6 × 104 0.41 1.0 × 107
TCRβ ABabDII 10 × 104 9.0 × 104 0.78 1.1 × 104 0.50 0.7 × 107
8 × 104 7.5 × 104 0.79 0.9 × 104 0.49 0.6 × 107
9 × 104 8.4 × 104 0.79 0.9 × 104 0.48 0.7 × 107
11 × 104 10.2 × 104 0.79 1.0 × 104 0.46 0.7 × 107
10 × 104 8.7 × 104 0.79 1.0 × 104 0.50 0.7 × 107
ABabDR4 12 × 104 11.0 × 104 0.77 1.4 × 104 0.51 0.8 × 107
12 × 104 11.1 × 104 0.77 1.4 × 104 0.51 0.9 × 107
13 × 104 11.7 × 104 0.76 1.5 × 104 0.51 0.9 × 107
16 × 104 14.1 × 104 0.76 1.8 × 104 0.51 0.9 × 107
17 × 104 15.0 × 104 0.75 1.9 × 104 0.50 1.0 × 107
Humans 13 × 104 12.3 × 104 0.92 3 × 104 0.17 0.6 × 107
14 × 104 13.2 × 104 0.91 2 × 104 0.14 0.7 × 107
10 × 104 9.6 × 104 0.92 2 × 104 0.18 0.7 × 107
nt, nucleotide.
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Most Vα–Jα and Vβ–Jβ gene combinations were detected in 
both the in-frame and the out-of-frame repertoire (Fig. 3). 
In general, the postselection repertoire for both the α and 
the β chains mirrored the usage pattern of the preselection 
repertoire similarly in ABabDII and ABabDR4 mice (Figs. 2 
and 3). However, we also observed changes in the pre- versus 
postselection repertoire for some V genes and V–J pairing (see 
I-Ab and HLA-DR4 have distinct imprint in TCR selection).
Figure 2. V and J gene usage frequencies 
of out-of-frame and in-frame tcr clo-
notypes. Frequencies include TCRα (A) and 
TCRβ (B) V gene or TCRα (C) and TCRβ (D) J 
gene usage of unique TCR clonotypes in CD4 
T cells of ABabDII mice (n = 5), ABabDR4 (n = 
5) mice and human donors (n = 3). The gene 
segments were arranged on the x axis accord-
ing to their position on the human chromo-
some from 5′ to 3′. TRAV18 usage was not 
detected, most likely because of PCR bias, and 
was excluded from the graph. Dashed line in-
dicates frequency for random V gene usage 
(TRAV, 2.3%; TRBV, 2.1%). All data are shown 
as means ± SD. *, V genes whose expression is 
missing in ABab transgenic mice.
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larger cd4 t cell repertoire in ABabdr4 
compared with ABabdII mice
ABabDII mice were able to select a diverse human TCR rep-
ertoire with a mean of 7.5 × 104 ± 0.60 × 104 in-frame 
TCRα and 8.8 × 104 ± 0.97 × 104 TCRβ amino acid clo-
notypes from the CD4 T cells submitted for sequencing 
(Fig. 4 A and Table 1). Thus, I-Ab molecules can positively 
select all human Vα–Jα and Vβ–Jβ combinations (Fig.  3). 
However, HLA-DR4 selected significantly more functional 
TCRα and TCRβ clonotypes compared with I-Ab from the 
same number of T cells (10.0 × 104 ± 0.87 × 104 and 12.6 × 
104 ± 1.83 × 104 TCRα and TCRβ clonotypes, respectively; 
Fig. 4 A and Table 1). Humans had the most TCRα clono-
types (14.8 × 104 ± 4.08 × 104), likely because of the effect 
of positive selection by multiple MHC II molecules but, sur-
prisingly, similar numbers of TCRβ clonotypes (11.7 × 104 ± 
1.89 × 104) compared with ABabDR4 mice.
There were more medium-to-large and fewer rare- 
to-small TCRα and TCRβ clonotypes in ABabDII mice than 
in ABabDR4 mice (Fig. 4, B and C). Most TCRα and TCRβ 
clonotypes were rare to small in the two younger human do-
nors. The third donor, aged 60 yr, had some hyperexpanded 
TCR clones and was not included in the clone-size compar-
ison. In general, ABabDR4 mice had a more homogenous 
TCRα and TCRβ distributions than ABabDII mice had (a 
mean inequality score of 0.65 ± 0.01 vs. 0.70 ± 0.03 for 
TCRα and 0.57 ± 0.07 vs. 0.66 ± 0.05 for TCRβ; Fig. 4 D). 
Two of the three human donors had the lowest inequality 
scores of all three groups.
Because only ∼0.5% of the total CD4 T cell repertoire 
from each mouse was sequenced, we applied a computational 
approach to determine the total TCR repertoire in CD4 T 
cells from the mice and humans. A lower-bound estimation 
on the TCR repertoire size was calculated with the acquired 
number of productive TCR sequences and the number of 
their templates detected in the sequencing samples using 
iCHAO1 estimator (Chiu et al., 2014). HLA-DR4 selected 
significantly more functional TCRα and TCRβ clonotypes 
(3.7 × 105 ± 0.4 × 105 and 6.9 × 105 ± 0.6 × 105 TCRα 
and TCRβ clonotypes, respectively) compared with I-Ab 
(2.4 × 105 ± 0.3 × 105 TCRα and 3.5 × 105 ± 0.2 × 105 
TCRβ clonotypes; Fig. 4 E). Humans had the most of both 
TCRα (7.2 × 105 ± 1.105) and β clonotypes (16.2 × 105 ± 
2.2 × 105), likely because of the effect of positive selection by 
multiple MHC II molecules.
Endogenous superantigens, such as the mouse mammary 
tumor virus (MMTV) superantigens, could alter CD4 T cell 
selection, e.g., deletion of T cells with certain Vβ segments, 
as observed in HLA-DR4 transgenic mice with a mouse 
TCR repertoire (Ito et al., 1996). We co-cultured purified 
CellTrace-labeled CD4 T cells from C57BL/6, ABabDII, 
ABabDR4 and DR4 mice with purified CD19+ cells from 
ABabDII, ABabDR4 or DR4 mice for 84 h. Compatible with 
superantigen recognition, C57BL/6 CD4 T cells responded 
to stimulation with B cells from DR4 and ABabDR4 mice, 
however, ABabDII and ABabDR4 mice, both expressing the 
human TCR repertoire, did not proliferate to the B cells of 
any mouse line (Fig. S3). Thus, we assume that human TCRs, 
unlike mouse TCRs, only weakly (or not at all) interact with 
MMTV and conclude that endogenous mouse superantigens 
did not obscure our results.
I-Ab and HlA-dr4 have distinct imprint in tcr selection
In general, after thymic selection the usage pattern remained 
similar for both Vα and Vβ to what it was before selection. 
However, we also observed changes for some V genes. For 
example, TRBV4-1 was strongly preferred by I-Ab, but not 
HLA-DR4, molecules (Fig.  2). Interestingly, TRBV4-1 is 
evolutionarily related to a mouse TCRβ chain (Vβ8.2) in 
the CDR2 region (Scott-Browne et al., 2011). Similarly, 
TRAV13-1 and TRBV2 were preferentially selected by 
I-Ab molecules. Conversely, some V genes were preferen-
tially selected by HLA-DR4 but not I-Ab molecules, i.e., 
TRBV3-1/2 and TRBV12-3/4.
To analyze the V gene usage pattern more globally, an 
unsupervised method, principle component analysis (PCA), 
was performed on the V gene usage profiles of the three 
groups. PCA separated the human samples on the dominant 
axis (PC1) but did not do so for the two mouse groups for 
both in-frame and out-of-frame TCRs, which was also re-
flected by their closed Euclidean distance (Vα: 3.0 and Vβ: 
2.3; Fig. 5, A–C). Before selection, the only variable among 
the three groups may have been solely species difference. 
Only after thymic selection did ABabDII and ABabDR4 
mice and humans separate from each other and cluster on the 
PC2 axis, suggesting that different MHC II and number of 
MHC II molecules influenced the V gene usage and similarly 
for Vα (Fig. 5 A) and Vβ genes (Fig. 5 B). Indeed, in-frame V 
gene usage was rather similar within groups (ED score ∼1–2) 
but significantly different between groups (Fig. 5 C). Based 
on that observation, we grouped the V genes whose usage 
frequency changed significantly compared with out-of-frame 
TCR for the two mouse strains into “overrepresented,” “un-
changed,” and “underrepresented” (Fig. 6 A). The same dis-
tribution pattern and clustering of the three groups in the 
post- versus preselection repertoire was observed for Vα–Jα 
and Vβ–Jβ combinatorial events (Fig. 5, D and E) and, sur-
prisingly, also for Jα and Jβ usage frequency (Fig. S4).
A skewed V–J pairing was observed for functional 
TCRα and β chains compared with the preselection pool 
(Fig.  3, A and B). ABabDII and ABabDR4 had almost the 
same out-of-frame V–J pairing patterns, and the TRAV13-
1-TRAJ-54/53 and TRBV28-TRBJ2-3/7 were the most 
prominently selected in both strains. Despite those similari-
ties, the two MHC II molecules also had their own features, 
e.g., TRBV12-3/4-TRBJ2-1 was the second most selected 
in ABabDR4 mice, whereas TRBV2-TRBJ2-7 was the one 
in ABabDII mice (Fig. 3 B). The distinctive patterns of V–J 
pairing between the two mouse strains, which are imposed 
by mouse or human MHC II, could also be seen in the PCA 
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Figure 3. Mean frequencies of V–J pairing of tcr clonotypes. Frequencies include TCRα (A) and TCRβ (B) V–J pairing of unique TCR clonotypes in 
ABabDII mice (n = 5), ABabDR4 (n = 5) mice, and human donors (n = 3). The heat maps were arranged by frequency from greatest (red) to the least (gray; 
top → bottom, J segments; left → right, V segments). (Left) In-frame; (Right) Out-of-frame. TRAV1, TRBV5-1, and TRBV6-1 were excluded from the analysis 
for ABabDII and ABabDR4 mice; TRAV18 was excluded for all three groups.
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analysis (Fig. 5, D and E) and, by comparison, in their Euclid-
ean distance (Fig. 5 F).
HlA-dr4 selects a longer tcrβ cdr3 compared with I-Ab
The V(D)J junctional region (CDR3) generates most di-
versity within the TCRs and is the major region for anti-
gen contact and recognition. ABabDII and ABabDR4 mice 
showed rather similar mean TCRα CDR3 length (∼42 bp) 
in the preselection as well as the postselection pool (Figs. 6 
B and 7 A). After selection, the CDR3 length distribution 
narrowed, but ABabDR4 mice contained a wider range of 
CDR3 length than ABabDII did. The TCRα CDR3 length 
distribution in humans was quite similar to that in the mice, 
yet slightly broader before or after selection (Fig. 7 A).
The TCRβ CDR3 length distribution also did not dif-
fer in the preselection pool between the two mouse strains; 
however, humans generated, on average, longer and broader 
CDR3 region (Fig. 7, B and C). After selection, the CDR3 
length distribution narrowed as seen for TCRα. The peak of 
CDR3 length remained the same in ABabDR4 mice post-
selection (42 bp), approaching that observed in humans, but 
decreased in ABabDII mice to 39 bp (Fig. 7, B and C). Most 
TCRβ chains selected by HLA-DR4 molecules had, on av-
erage, one amino acid longer CDR3 compared with those 
selected by I-Ab molecules (Fig. 7, B and C). On average, 
CDR3 was longer in humans, compared with the two mouse 
strains in both the pre- and postselection repertoire, which 
was more apparent for the TCRβ chain, likely because of two 
recombinatorial events (V–D–J; Fig. 7 C).
To determine whether the human MHC II molecule is 
imprinted to select for longer CDR3, we deep-sequenced 
the mouse TCRβ repertoire from CD4 T cells isolated from 
Figure 4. comparison of tcrα and tcrβ repertoire among ABabdII mice, ABabdr4 mice, and human donors. (A) Absolute numbers of unique TCR 
amino acid clonotypes within 2.5 × 105 mouse or 1.8 × 105 human CD4 T cells. (B) Distribution of TCR amino acid clonotypes of different sizes: rare, 0 < x 
≤ 0.001%; small, 0.001% < x ≤ 0.01%; mediumm 0.01% < x ≤ 0.1%; large, 0.1% < x < 1%; hyperexpanded (hyperexpan.), 1% < x < 10%. Human donor 3 
was omitted from this analysis. Mann–Whitney test was used to compare clonotype sizes between ABabDII and ABabDR4 mice. (C) Percentage of medium 
to hyperexpanded TCR amino acid clonotypes of the total clonotypes. (D) Gini index indicating the equality of distribution of TCRα and TCRβ clonotypes (in-
equality). (E) Numbers of unique TCRα and TCRβ calculated using the iCHAO1 estimator. Data are from ABabDII (n = 5); ABabDR4 (n = 5) mice, and humans 
(n = 2 for B; n = 3 for A, C, and D). Mann–Whitney test (two-tailed) was used to compare values between ABabDII and ABabDR4 mice. **, 0.001 ≤ P < 0.05; 
*, 0.05 ≤ P < 0.1; n.s., not significant (Mann–Whitney test). Data from ABabDII and ABabDR4 mice are shown as means ± SD. Means and SD for humans are 
not depicted. In addition, Table 1 provides a summary of sequencing data and Fig. S2 provides further Treg and Tcon analysis.
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three C57BL/6 mice. Mouse TCRβ selected on the mouse 
I-Ab molecule showed a rather similar mean CDR3 length to 
ABabDR4 mice and human postselection (Fig. 7, B and C). 
Thus, selection of TCRβ chains with shorter CDR3 was a 
specific feature of ABabDII mice.
CDR3 length is the net result of exonuclease and ter-
minal deoxynucleotidyl transferase (TdT) activity. ABabDII, 
ABabDR4, and C57BL/6 mice had similar exonuclease and 
TdT activity, reflected by their almost identical number of 
bp deletions and insertions in the CDR3 region of TCRα 
(Fig. 7 D) and β chains (Fig. 7, D and E). Compared with 
mice, humans revealed, on average, more deletions and inser-
tions and, thus, had more exonuclease and TdT activity. When 
analyzing the CDR3 length in groups according to their V 
Figure 5. PcA correlations among mice and humans for V and V–J usage. PCA shows the correlation between ABabDII mice (blue dots), ABabDR4 
mice (red dots), and human donors (gray dots) for their TRAV usage (A) and TRBV usage (B) of unique TCR clonotypes. (Left) PCA of in-frame sequences; 
(right) PCA for out-of-frame sequences. TRAV1-1, TRAV1-2, TRBV5-1, and TRBV6-1 were excluded. Each dot represents an individual of ABabDII mice, 
ABabDR4 mice, or humans. Proportions of variance (PC1 and PC2) are indicated at the axis. (C) Comparisons of V segment usages restricted to the same or 
different MHC alleles. (Left) Similarity comparisons of out-of-frame V gene usages in ABabDII and ABabDR4. (Right, top and bottom lanes) Similarity com-
parisons of in frame V segment usages within and between groups of ABabDII mice, ABabDR4 mice, and humans and to the out-of-frame sequences. (Top) 
TCRα (TRAV) V segments; (bottom) TCRβ (TRBV) V segments. (D and E) PCA of TRAV-J (D) and TRBV-J (E) pairing usage of unique TCR clonotypes, arranged 
the same as in A and B. (F) Comparisons of V–J pairing usages restricted to the same or different MHC allele(s), arranged the same as in C. ***, P ≤ 0.001; 
**, 0.001 ≤ P < 0.05; and *, 0.05 ≤ P < 0.1; n.s., not significant (Mann–Whitney test, two-tailed). ED, Euclidean distance. Data are from ABabDII mice (n = 5), 
ABabDR4 mice (n = 5), and humans (n = 3). Fig. S4 provides PCA analysis of J segment usages.
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gene usage frequencies, the underrepresented Vβ genes in 
ABabDII mice had, on average, the shortest CDR3 length, 
whereas in ABabDR4 mice, they had, on average, the longest 
CDR3 length (Fig. 6 B).
shared tcrα and β clonotypes
The number of shared clonotypes (based on amino acid se-
quences) after selection within and between the two mouse 
strains and humans was strikingly greater than if the repertoire 
is created randomly (Fig. S5, A and B; Robins et al., 2010). 
More shared clonotypes were detected within, compared 
with between, groups (Fig. 8), and ABabDR4 shared more 
clonotypes among each other (Jaccard index: 0.224 ± 0.006 
for TCRα and 0.076 ± 0.003 for TCRβ) than ABabDII mice 
did (0.193 ± 0.006 for TCRα and 0.067 ± 0.002 for TCRβ).
The number of shared clonotypes beyond MHC re-
striction was surprisingly high, and the number of shared 
TCRα clonotypes (0.189 ± 0.006) was significantly greater 
than shared TCRβ (0.041 ± 0.002) between ABabDII and 
ABabDR4 mice, likely because of one compared with two 
Figure 6. Grouped V gene analysis. (A) Heat 
maps of TCR V gene usage changes after thy-
mic selection. Red represents the V genes that 
were overpresented after thymic selection, 
yellow were the ones unchanged, and gray to 
blue were ones that were underrepresented. 
Values were calculated as log2 of the ratio of 
Frequency Vin-frame/Frequency Vout-of-frame. (B) V 
genes were grouped into overrepresented, un-
changed, or underrepresented, and their CDR3 
length distributions are shown in bars (mean 
± SD). Gaussian distributions were assumed 
and are shown in lines for all groups. Data are 
from ABabDII mice (n = 5), ABabDR4 mice (n = 
5), and humans (n = 3).
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somatic recombination events. ABabDII and ABabDR4 
generated more shared TCRα and β than they shared with 
humans (ABabDII with humans: TCRα 0.072 ± 0.017 and 
TCRβ 0.0057 ± 0.001; ABabDR4: TCRα 0.082 ± 0.020 and 
TCRβ 0.0070 ± 0.001), most likely because of the higher 
genetic similarity between the two mouse strains. Notably, 
random recombination would yield virtually no shared clo-
notypes within 2.5 × 105 CD4 T cells. The shared clonotypes 
within and among groups cumulated linearly with the in-
crease in total clonotypes (Fig. S5 B).
Figure 7. cdr3 region analysis. CDR3 length distribution of TCRα (A) and TCRβ (B) clonotypes. For the in-frame clonotypes, the frequencies of different 
CDR3 lengths for ABabDII mice, ABabDR4 mice, humans, and C57BL/6 mice (only TCRβ) are shown in bar diagrams. For the out-of-frame clonotypes, only 
the mean frequency and SD for each CDR3 length are shown for each group at the corresponding length. Gaussian distributions were assumed and are 
shown as lines for all groups, including the C57BL/6 CDR3β (purple, dotted lines; R2 ≥ 0.99 for all samples). (C) Comparison of means of CDR3β lengths 
among ABabDII, ABabDR4, and C57BL/6 mice and humans. (D) Frequency of TCRs with the same number of CDR3 nucleotide insertions for TCRβ chains; in-
sertions in C57BL/6 mice were included (purple dotted lines). (E) Frequency of TCRs with the same number of CDR3 nucleotide deletion of TCRβ chains from 
ABabDII mice, ABabDR4 mice, humans, and C57BL/6 mice. (D and E, left) Out-of-frame clonotypes from TCRα (top)/β (bottom). (D and E, right) In-frame. 
For all panels, **, 0.001 ≤ P < 0.05; n.s., not significant (Mann–Whitney test, two-tailed). Data are shown as means ± SD. Data are from ABabDII (n = 5), 
ABabDR4 (n = 5), and C57BL/6 (n = 3) mice and humans (n = 3).
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stronger cd4 t cell responses in 
ABabdr4 compared with dr4 mice
We investigated whether ABabDR4 mice could more effi-
ciently respond to immunization than did DR4 mice ex-
pressing a mouse TCR repertoire selected on HLA-DR4. 
Therefore, we immunized ABabDR4 and DR4 mice with 
the two HLA-DR4–presented peptides derived from 
hemagglutinin (HA307–319) or PTPN11mut. PTPN11mut is a 
somatic mutation in cancer with a single amino acid sub-
stitution but is otherwise identical to the mouse homo-
logue. The percentage of IFN-γ+ CD4 T cells in response 
to both peptides was significantly higher in ABabDR4 
compared with DR4 mice (0.37% ± 0.22% vs. 0.04% ± 
0.04% for HA307–319 and 0.15% ± 0.06% vs. 0.03% ± 0.02% 
for PTPN11mut peptide, respectively; Fig. 9). The data sug-
gest that ABabDR4 have more HA307–319 and PTPN11mut 
CD4 T cell precursors than DR4 mice.
dIscussIon
We felt that the controversial discussion about whether and 
how the TCR and MHC coevolved reached a dead end with 
good arguments for either site. This is because, in most cases, 
single TCR–pMHC interactions were analyzed, either by re-
solving crystallographic structures or by analyzing mutations 
in the germline-encoded CDR1 and CDR2 (Marrack et al., 
2008; Rossjohn et al., 2015). Although the data provided con-
vincing evidence for TCR–MHC coevolution, inherent in 
the immune system, there are usually exceptions to that rule, 
so that it is not always easy to distinguish what is the excep-
tion and what is the rule. For example, a TCR germline bias 
(Garcia et al., 2009) is difficult to reconcile with the obser-
vation that 85% of the thymocytes do not receive a selection 
signal and, therefore, apparently lack a sufficient affinity for 
self-pMHC and that only 7.5% of the thymocytes are MHC 
or pMHC cross-reactive (Blackman et al., 1986; Merken-
Figure 8. tcr shared repertoire analysis from ABabdII mice, ABabdr4 mice, and humans. Jaccard index scores within and between groups of ABab-
DII mice, ABabDR4 mice, and human samples for both TCRα (A) and TCRβ (B). **, 0.001 ≤ P < 0.05; ***, P ≤ 0.001 (Mann–Whitney test, two-tailed). The data 
shown are means ± SD from ABabDII mice (n = 5), ABabDR4 mice (n = 5), and humans (n = 3). Additional information in Fig. S5.
Figure 9. comparison of cd4 t cell re-
sponses against two HlA-dr4 epitopes 
between dr4 and ABabdr4 mice. ABabDR4 
and DR4 mice were immunized twice with 
hemagglutinin peptide 307–319 (HA) or 
PTPN11G503A peptide 492–506 (PTPN11mut). 
At 2 wk after the second immunization, CD4 
T cell responses were detected with peptide 
restimulation of draining LN cells, followed 
by intracellular IFN-γ staining. Percentages 
of IFN-γ+ CD4 T cells were measured by flow 
cytometry. Gates were set on live CD3+ lym-
phocytes. Each dot represents one mouse. Re-
sults are from two experiments combined and 
shown as mean ± SD. ***, P < 0.001 (Mann–
Whitney test, two-tailed).
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schlager et al., 1997; Zerrahn et al., 1997; Huseby et al., 2005; 
McDonald et al., 2015). Therefore, we addressed the issue dif-
ferently, based on the assumption that evolving differences in 
the inherent affinity between TCR and MHC in mice and 
humans are subtle and that thymic selection is the most sen-
sitive read-out to detect such differences. We investigated the 
human αβ TCR repertoire because previous studies focused 
mainly on mouse TCR–MHC interactions, and we analyzed 
the polyclonal repertoire to encompass the ability of a single 
MHC allele to select T cells with any possible, functionally 
rearranged TCR. By comparing the pre- and postselection 
repertoire selected on a single mouse or human MHC II al-
lele, we indirectly addressed the inherent germline-encoded 
affinity for any human Vα (Jα) or Vβ (Jβ) segment, which 
evolved during the some 70-million-year divergence of ro-
dents and humans. Our conclusions became apparent only 
through massive parallel TCR deep sequencing.
Both TCRα and TCRβ V–J gene usage in CD4 T cells 
as well as V–J combinatorial frequencies are highly biased, 
dramatically limiting the theoretically possible T cell reper-
toire, which was known for the TCRβ repertoire (Robins 
et al., 2010; Rubelt et al., 2016). The nonrandom usage is 
hardwired in the human TCR gene loci. It is imprinted in the 
postselection repertoire but shaped by the respective selecting 
MHC II molecule, shown by the PCA, and the higher num-
ber of shared clonotypes within than between the two mouse 
lines. Surprisingly, many TCRβ clonotypes were shared, and 
even more TCRα clonotypes were shared between humans 
and human MHC II-expressing mice. ABabDR4 mice shared 
more TCR clonotypes (11% ± 0.3% TCRα and 1.3 ± 0.1% 
TCRβ chains) with humans than ABabDII mice did (9.6% 
± 0.2% TCRα and 1.1 ± 0.2% TCRβ). The abundance of 
shared TCRα or TCRβ single chains between different spe-
cies and, independent of the MHC II profile, suggests that αβ 
chain combinatorial pairing has a larger role for creating di-
versity than previously thought (Arstila et al., 1999). We could 
not detect more shared clonotypes between ABabDR4 mice 
and the only HLA-DR4+ human, which is not surprising 
because humans bear six MHC II alleles, and which TCR is 
restricted to which MHC II allele is not known.
Mouse MHC II molecules almost perfectly select a human 
TCR repertoire, but only, almost. Basically, all human TCRα 
V-J and TCRβ V–D–J gene combinations were detected in the 
postselection repertoire of ABabDII mice, demonstrating that 
“structurally coded recognition motifs for MHC” (Marrack et 
al., 2008; Garcia et al., 2009) have been selected and fixed in 
most human V genes before mouse–human divergence. How-
ever, ABabDII mice had reduced thymic output and a greater 
clonality. The difference in I-Ab and HLA-DR4 in selecting 
a human TCR repertoire became clearly visible in the global 
comparison when ABabDR4 mice generated 30% more of 
both TCRα and TCRβ unique clonotypes (amino acids) than 
did ABabDII mice. This provides a strong hint that mouse 
MHC II molecules, at least I-Ab, do not select as efficiently a di-
verse, human αβ TCR repertoire as human MHC II molecules.
The increased TCR repertoire selected by HLA-DR4 
compared with I-Ab molecules is likely due to a slightly in-
creased inherent affinity, likely in the CDR1 and CDR2 re-
gions (Marrack et al., 2008), of many human Vα genes for 
HLA-DR4. The increased TCRβ repertoire in ABabDR4, 
compared with ABabDII, mice is directly reflected in the 
CDR3 length. ABabDII and ABabDR4 mice revealed sim-
ilar CDR3β length distribution in the preselection reper-
toire. After selection, the mean length of CDR3β selected 
by human MHC II in ABabDR4 mice and humans was one 
amino acid longer than that selected by mouse MHC II. 
The mean, shorter CDR3β was not seen in C57BL/6 mice, 
where the TCR and MHC were species compatible. Thus, 
the most likely explanation is that species-specific TCRs 
evolved to have an optimal intrinsic affinity for their own 
MHC or vice versa. Assuming that the intrinsic affinity is not 
optimal between many human TCRs and mouse MHC II, 
the peripheral CD4 T cell repertoire in ABabDII mice had to 
adopt a shorter CDR3 domain to become positively selected 
(Gilfillan et al., 1995; Marten et al., 1999; Yassai et al., 2002). 
Shorter CDR3 domains increase the risk that T cells will be 
cross-reactive (Gavin and Bevan, 1995; Huseby et al., 2008). 
In line with that finding, ABabDR4 mice had more periph-
eral Tcon cells, compared with ABabDII mice and, interest-
ingly, the frequency of Treg within the CD4 T cell population 
was substantially higher in ABabDII (19.9 ± 4.4%) compared 
with ABabDR4 mice (10.8 ± 4.0%). Thus, we assume that 
CD4 T cells selected for short CDR3 of human TCRs by 
mouse MHC II are at higher risk of ending as Tregs because 
of cross-reactivity. Collectively, the interspecies incompatibil-
ity between TCR and MHC further supports TCR–MHC 
coevolution after divergence of the two species. However, 
the TCR repertoires selected by the closest homologues, e.g., 
I-Ab and HLA-DQ, need to be analyzed.
In ABabDII mice, underrepresented V genes seem 
to have suboptimal affinity for the I-Ab molecule because 
their CDR3 were, on average, the shortest. In contrast, the 
underrepresented V genes selected by HLA-DR4 had, on 
average, the longest CDR3. Thus, the underrepresented 
human V genes in ABabDII mice may have retained or 
gained affinity for HLA-DR4 but lost it for I-Ab. On the 
other hand, the underrepresented V genes in ABabDR4 
mice may have a too-high, inherent affinity for HLA-DR4, 
assuming that longer CDR3 decrease the affinity. The pic-
ture may change with different MHC II alleles; each of 
which, may have a set of preferred and nonpreferred V 
genes (Sharon et al., 2016). We hypothesize that different, 
inherent affinity of any V segment for any MHC allele is 
adjusted by CDR3 length, ensuring that T cells with any 
V segment can be positively selected by any MHC allele, 
which is supported by the diverse human TCR repertoire 
in ABabDII mice. HLA-DR4 is capable, but less efficient, 
in selecting a mouse TCR repertoire than I-Ab because 
CD4 T cell responses were less efficient in HLA-DR4 
transgenic, compared with ABabDR4, mice.
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Mice generate, on average, a shorter TCRβ CDR3 re-
gion than do humans, which can be seen in the preselection 
repertoire. Surprisingly, the human recombination machin-
ery evolved to both excise and add more nucleotides in the 
TCRβ V–D and D–J junctional regions, which is executed 
by combined exonuclease and TdT activity. Both enzymatic 
activities might increase TCR diversity. This evolutionary 
process provides a reasonable explanation for the larger T 
cell repertoire in humans, which was estimated to be 20-fold 
higher than that of mice (Arstila et al., 1999; Casrouge et al., 
2000; Nikolich-Žugich et al., 2004; Vrisekoop et al., 2014).
In conclusion, our findings suggest that human TCRα 
and TCRβ V genes acquired an inherent affinity for MHC II 
before separation of rodents and humans. Afterward, human 
MHC and TCR gene loci further coevolved to maintain in-
herent affinity, and in order to compensate for nonrandom 
V(D)J usage, to increase T cell diversity by focusing on larger 
nontemplate-encoded CDR3 diversity. Our data also suggest 
that CDR3 length adjusts for different inherent V segment–
MHC affinity and that T cells with shorter CDR3β are at 
increased risk of becoming Tregs.
MAterIAls And MetHods
Mice
All mouse studies were performed in accordance with insti-
tutional, state, and federal (Landesamt für Arbeitsschutz, Ge-
sundheitsschutz und technische Sicherheit, Berlin, Germany) 
guidelines. C57BL/6 and HLA-DR4 mice were purchased 
from The Jackson Laboratory and Taconic, respectively. ABab-
DII transgenic mice have been previously described (Li et 
al., 2010). ABabDR4 mice were established by crossing ABab 
transgenic mice (Li et al., 2010) to HLA-DR4 mice (Ito et 
al., 1996) and selecting mice homozygous for human TCRα 
and TCRβ gene loci, HLA-DR4 transgene, as well as mouse 
TCRα, TCRβ, I-Eα, and I-Aβ deficiency. The genotype of 
the mice was confirmed by PCR. Mice were bred in the 
Max-Delbrück-Center animal facility under specific patho-
gen–free condition and were on a mixed 129SV, C57BL/6, 
and BALB/c genetic background. Mice aged between 8 and 
16 wk were used in this study.
Human donors
Three healthy human donors, aged 30, 48, and 60 yr at the 
time of blood collection, volunteered to donate blood with 
informed consent. Blood collecting and processing was 
performed according to human experimental guidelines 
under license EA4/046/10 (Ethikkommission). The MHC 
II profiles were determined by genotyping (Zentrum für 
Humangenetik und Laboratoriumsdiagnostik, Martinsried, 
Germany). Details are as follows: donor 1: HLA-DRB1 
08:01, 11:12; HLA-DRB3 02; HLA-DQB1 03:01, 04:02; 
HLA-DPB1 03:01, 04:02; donor 2: HLA-DRB1 04:01, 
15:01; HLA-DRB4 01:03; HLA-DRB5 01:01; HLA-DQA1 
01:02, 03:01; HLA-DQA1 01:02, 03:01; HLA-DQB1 03:02, 
06:02; HLA-DPA1 01:03; HLA-DPB1 04:01; and donor 3: 
HLA-DRB1 01:01, 13:01; HLA-DRB3 02:02; HLA-DQA1 
01:01, 01:03; HLA-DQB1 05:01, 06:03; HLA-DPA1 01:03; 
HLA-DPB1 04:01.
Flow cytometry
Fluorochrome-conjugated antibodies specific for mouse 
CD4 (GK1.5), CD8a (53–6.7), CD5 (53–7.3, isotype: rat 
IgG2a, κ), IFN-γ (XMG1.2), CD45 (30-F11, isotype: rat 
IgG2b, κ), CD326 (EpCAM, G8.8, isotype: rat IgG2α, κ), 
I-Ab (AF6-120.1), CD11c (N418), and FoxP3 (MF-14), 
and human CD3 (HIT3a), CD8a (HIT8a), CD4 (OKT4), 
CD45RA (Hl100), CD45RO (UCHL1), and CD62L 
(DREG-56) were obtained from BioLegend. Mouse CD3ε 
(145-2C11), CD69 (H1.2F3, isotype: Armenian hamster 
IgG), Ly51 (6C3, isotype: rat IgG2a, κ), and HLA-DR 
(L243) specific antibodies were purchased from BD. The 
TCR Vβ repertoire kit (IOTest Beta Mark) was purchased 
from Beckman Coulter. UEA I lectin was obtained from 
GeneTex. Thymus, spleen, and LNs from 1–2-mo-old 
C57BL/6, ABabDII and ABabDR4 mice were isolated. 
Cells were obtained by mashing the organs through a 0.45-
µm cell strainer. Isolation of thymic DCs and epithelial cells 
was performed as published (Xing and Hogquist, 2014). 
In brief, thymic lobes were digested in enzyme solution 
(RPMI-1640 medium with 0.05% Liberase TH and 100 
U/ml of DNase I) at 37°C for 20 min. Single cells were 
then stained with antibodies specified in the respective fig-
ure legends and analyzed by flow cytometry (FAC SCanto 
II; BD). FoxP3 staining was performed with True-Nuclear 
transcription factor buffer set from BioLegend.
FAcs sorting
For mouse CD4 T cells, pooled cells from mouse spleen 
and LNs were collected. For human naive (CD45RO− and 
CD62L+) CD4 T cell isolation, ∼50  ml fresh blood from 
human donors was collected, and PBMCs were isolated by 
the Ficoll density centrifugation method. The cells were 
sorted by a FACS sorter (FAC SAR IA III; BD), and the purity 
for all samples was >95%.
Assay for detection of MMtV
Mouse CD4 T cells and CD19 cells from spleens of C57BL/6, 
DR4, ABabDII, and ABabDR4 mice were purified using 
mouse CD4+ T cell isolation kit and CD19 MicroBeads 
(Miltenyi Biotec). Subsequently, the purified CD4 T cells 
were labeled with CellTrace Violet (Thermo Fisher Scien-
tific). 3 × 105 labeled CD4 T cells were co-cultured with 1.5 
× 106 CD19 cells from different mouse strains at a ratio of 
1:5 in a 96-well, round-bottom plate for 84 h at 37°C, with 
5% CO2. Measurement of the proliferated CD4 T cells was 
accessed by flow cytometry.
Genomic dnA isolation and tcr deep sequencing
Genomic DNA was extracted with the QIA GEN blood and 
tissue kit, quantified with a NanoDrop 1000 (Thermo Fisher 
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Scientific), and stored at −80°C. TCRα and TCRβ deep se-
quencing and quantification was performed on an immuno-
SEQ platform (Adaptive Biotechnologies). The technique has 
a sensitivity of 1 in 200,000 T cells and was optimized to min-
imize the effect of PCR bias introduced in the first multiplex 
PCR step (Robins et al., 2009; Carlson et al., 2013). 1.2 µg 
of genomic DNA, which corresponds to ∼2.5 × 105 mouse 
and ∼1.8 × 105 human CD4 T cells, was sequenced for each 
sample. TCR sequences were delineated according to the 
definition established by the International ImMunoGeneTics 
Information System collaboration.
Immunization
ABabDR4 and DR4 mice were immunized twice at an in-
terval of 4 wk. 80 µg hemagglutinin peptide HA307–319 (KYV 
KQN TLK LATG) or mutant peptide PTPN11492–506 (KTI 
QMV RSQ RSM VQ; G503A mutation), mixed with 100 µl 
IFA, and 50 µg CpG oligonucleotides were injected s.c. on 
both sides of the tail base of each mouse. 14 d after the sec-
ond immunization, the draining LNs were isolated, single 
cells were restimulated in vitro for 12  h with the respec-
tive peptides, and the IFN-γ production by CD4 T cells was 
measured intracellularly using the kit and protocol from BD 
(Cytofix/Cytoperm kit).
data analysis
Data analysis and statistics were performed in Excel (Micro-
soft), R (R Foundation for Statistical Computing), and Prism 
(GraphPad Software).
Gene segment (V, J and V-J pairing) frequencies. Calculation 
of random distribution frequencies was estimated by the re-
ciprocal of the total number of functional TCR genes 
(V, J, or V–J pairing).
icHAo1 estimator. The TCRα and β repertoire sizes of 
ABabDII and ABabDR4 mice and humans were estimated 
based on the deep-sequenced samples using iCHAO1 estima-
tor provided with the immunoSEQ platform (Chiu et al., 2014).
Inequality score. Inequality (Gini index) analysis on the 
in-frame TCR amino acid clonotypes was based on the 
Lorenz curve.
PcA. PCA was performed based on V, J, or V–J combinatorial 
frequencies from ABabDII and ABabDR4 mice and humans 
with the “prcomp” function in R software without data nor-
malization (centralizing data). TRAV1, TRBV5-1, and 
TRBV6-1 were excluded from the analysis because they 
were known to be missing in the transgenic mouse repertoire.
euclidean distance. The Euclidean distance (ED score) was 
calculated, as shown in Eq. 1, to evaluate the similarities of V 
gene or V–J pairing usage frequencies within and between 
different groups:
  ED score =    √ 
________________
  ​∑​
i
   ( V group1 i​ ​−​​V group2 i ) 2 . (1)
estimation of Gaussian cdr3 length distribution. All CDR3 
lengths from ABabDII and ABabDR4 mice and humans were 
assumed to have a Gaussian distribution (R2 > 0.99). We used 
the variance (square of the SD) of the predicted Gaussian 
curve to depict the width of the CDR3 distributions.
Absolute number of shared clonotypes. The number of shared 
clonotypes from any two of the reshaped samples was calcu-
lated using the “intersect” function in R software, package 
tcR (Nazarov et al., 2015).
Jaccard index for similarity analysis. The αβ TCR similarities 
between any two samples were evaluated with the Jaccard 
index, which uses the number of shared TCR clonotypes by 
the number of total clonotypes from the two sam-
ples, as shown in Eq. 2:
  J ( A, B ) =  | A​​∩​  B |​ / ​| A  ∪  B | , (2)
where A and B represent TCRα or β repertoires from 
any two samples.
sample size. No specified effect size was used to determine 
sample sizes.
data availability
TCR sequencing data underlying this study can be analyzed 
and downloaded from the Adaptive Biotechnologies 
immuneACC ESS site at https ://doi .org /10 .21417 /B7ZD0D.
online supplemental material
Fig. S1 includes MHC II staining of thymic APCs from 
C57BL/6, ABabDII, and ABabDR4 mice. Fig. S2 includes 
additional data related to Fig. 1, showing FoxP3 and CD44 
frequencies in C57BL/6, ABabDII, and ABabDR4 mice, in-
cluding one representative staining and total columns for Treg 
and Tcon Vβ usages in ABabDII and ABabDR4 mice. Fig. S3 
shows CD4 T cell responses to MMTV superantigen-present-
ing CD19 cells from C57BL/6, DR4, ABabDII, and ABabDR4 
mice. Fig. S4 includes additional data related to Fig. 5, showing 
PCAs of TRAJ/BJ usages in ABabDII and ABabDR4 mice 
and human donors. Fig. S5 includes additional data related to 
Fig. 8, showing the absolute TCRα/β clonotypes shared either 
in total or from the most- to the least-abundant clonotypes 
among ABabDII and ABabDR4 mice and human donors.
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